Recruiting
Phase 3

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Sponsor:

Janssen Research & Development, LLC

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information